The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.
We studied 211 hyperandrogenic women with respect to clinical presentation, basal androgen levels, and the degree of cortisol and androgen suppression during a 48-h low-dose (2 mg) dexamethasone-suppression test (LDDST) to exclude ovarian and adrenal tumors. In 42 women with elevated testosterone le...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2003
|
| _version_ | 1797086338097348608 |
|---|---|
| author | Kaltsas, G Isidori, A Kola, B Skelly, R Chew, S Jenkins, P Monson, J Grossman, AB Besser, G |
| author_facet | Kaltsas, G Isidori, A Kola, B Skelly, R Chew, S Jenkins, P Monson, J Grossman, AB Besser, G |
| author_sort | Kaltsas, G |
| collection | OXFORD |
| description | We studied 211 hyperandrogenic women with respect to clinical presentation, basal androgen levels, and the degree of cortisol and androgen suppression during a 48-h low-dose (2 mg) dexamethasone-suppression test (LDDST) to exclude ovarian and adrenal tumors. In 42 women with elevated testosterone levels, 21 of whom failed to suppress testosterone during the LDDST, the response of serum androgen levels during a 4-wk administration of 7.5 mg prednisolone in a reverse circadian regimen was also assessed. These results were compared with an additional 17 patients with histologically proven androgen-secreting tumors. Clinical presentation alone was suggestive of a virilizing tumor in 70% of patients with tumors. Serum testosterone, although occasionally only marginally elevated, was the sole androgen that was elevated in every patient with a tumor. After the LDDST, none of the patients with tumors obtained either a greater than 40% reduction or normalization of the previously elevated testosterone levels, whereas 88% of patients with nontumorous hyperandrogenism showed either normalization or suppression of more than 40%. With one exception, all of the patients with nontumorous hyperandrogenism who showed inadequate suppression of testosterone during the LDDST, and were treated with prednisolone, normalized the previously elevated androgens after 1 month of administration. In summary, in women presenting with hyperandrogenism, lack of testosterone suppression during the LDDST is associated with 100% sensitivity and 88% specificity in distinguishing patients with ovarian and adrenal androgen-secreting tumors from patients with nontumorous hyperandrogenism in this small series. The LDDST is an easy to perform screening test that can also identify causes of hyperandrogenism due to altered glucocorticoid secretion. |
| first_indexed | 2024-03-07T02:20:34Z |
| format | Journal article |
| id | oxford-uuid:a3c4a3cc-11f7-473b-85ee-0a929802638f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:20:34Z |
| publishDate | 2003 |
| record_format | dspace |
| spelling | oxford-uuid:a3c4a3cc-11f7-473b-85ee-0a929802638f2022-03-27T02:29:20ZThe value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a3c4a3cc-11f7-473b-85ee-0a929802638fEnglishSymplectic Elements at Oxford2003Kaltsas, GIsidori, AKola, BSkelly, RChew, SJenkins, PMonson, JGrossman, ABBesser, GWe studied 211 hyperandrogenic women with respect to clinical presentation, basal androgen levels, and the degree of cortisol and androgen suppression during a 48-h low-dose (2 mg) dexamethasone-suppression test (LDDST) to exclude ovarian and adrenal tumors. In 42 women with elevated testosterone levels, 21 of whom failed to suppress testosterone during the LDDST, the response of serum androgen levels during a 4-wk administration of 7.5 mg prednisolone in a reverse circadian regimen was also assessed. These results were compared with an additional 17 patients with histologically proven androgen-secreting tumors. Clinical presentation alone was suggestive of a virilizing tumor in 70% of patients with tumors. Serum testosterone, although occasionally only marginally elevated, was the sole androgen that was elevated in every patient with a tumor. After the LDDST, none of the patients with tumors obtained either a greater than 40% reduction or normalization of the previously elevated testosterone levels, whereas 88% of patients with nontumorous hyperandrogenism showed either normalization or suppression of more than 40%. With one exception, all of the patients with nontumorous hyperandrogenism who showed inadequate suppression of testosterone during the LDDST, and were treated with prednisolone, normalized the previously elevated androgens after 1 month of administration. In summary, in women presenting with hyperandrogenism, lack of testosterone suppression during the LDDST is associated with 100% sensitivity and 88% specificity in distinguishing patients with ovarian and adrenal androgen-secreting tumors from patients with nontumorous hyperandrogenism in this small series. The LDDST is an easy to perform screening test that can also identify causes of hyperandrogenism due to altered glucocorticoid secretion. |
| spellingShingle | Kaltsas, G Isidori, A Kola, B Skelly, R Chew, S Jenkins, P Monson, J Grossman, AB Besser, G The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. |
| title | The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. |
| title_full | The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. |
| title_fullStr | The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. |
| title_full_unstemmed | The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. |
| title_short | The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. |
| title_sort | value of the low dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women |
| work_keys_str_mv | AT kaltsasg thevalueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT isidoria thevalueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT kolab thevalueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT skellyr thevalueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT chews thevalueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT jenkinsp thevalueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT monsonj thevalueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT grossmanab thevalueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT besserg thevalueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT kaltsasg valueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT isidoria valueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT kolab valueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT skellyr valueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT chews valueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT jenkinsp valueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT monsonj valueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT grossmanab valueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen AT besserg valueofthelowdosedexamethasonesuppressiontestinthedifferentialdiagnosisofhyperandrogenisminwomen |